(Q43719943)

26 November 2017

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa (English)

1 reference

26 November 2017

0 references

1 reference

2

1 reference

26 November 2017

F Simondon

6

0 references

author name string

H C Whittle

1

1 reference

26 November 2017

B Samb

3

1 reference

26 November 2017

H Jensen

4

1 reference

26 November 2017

J Bennett

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

26 November 2017

1 reference

26 November 2017

353

1 reference

26 November 2017

98-102

1 reference

26 November 2017

9147

1 reference

Further-attenuated measles vaccine: characteristics and use.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Measles outbreak in a fully immunized secondary-school population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Decline in measles case fatality ratio after the introduction of measles immunization in rural Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Measles and pertussis in developing countries with good vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Assessing vaccine efficacy in the field. Further observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Role of Schools in the Transmission of Measles In Rural Senegal: Implications for Measles Control In Developing Countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Child mortality after high-titre measles vaccines: prospective study in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Pattern of exposure and measles mortality in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Seroconversions in unvaccinated infants: further evidence for subclinical measles from vaccine trials in Niakhar, Senegal.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Clustering of haemagglutinin gene sequences of measles viruses isolated in the Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Temporal and geographical distribution of measles virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Gamma-globulin and acquired immunity to human malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Secondary failure rates of measles vaccines: a metaanalysis of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Overcrowding and intensive exposure as determinants of measles mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

10.1016/S0140-6736(98)02364-2

Identifiers

DOI

1 reference

26 November 2017

1 reference